Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
CONCLUSIONS: PFO-C after cryptogenic ischemic stroke is safe and effective to reduce the risk of recurrent stroke and recurrent stroke + TIA, albeit with an increased risk for NOAF.
PMID: 29500568 [PubMed - as supplied by publisher]
Source: Clin Med Res - Category: Research Authors: Schulze V, Lin Y, Karathanos A, Brockmeyer M, Zeus T, Polzin A, Perings S, Kelm M, Wolff G Tags: Clin Res Cardiol Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Heart | Ischemic Stroke | Patent Foramen Ovale | Research | Stroke | Thrombosis